The company also saw import declines driven by Section 232 tariffs, which were offset by a domestic surge in steel mill ...

Q3 2025 Earnings Call Transcript November 3, 2025 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS ...

Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...

Net loss for the third quarter of 2025 was $74.1 million, compared to a net loss of $54.4 million for the third quarter of 2024. Net loss for the third quarter included non-cash share-based ...

As a reminder, the company's Midlothian cement plant, related cement terminals and Texas ready-mixed concrete plants are classified as assets held for sale as of September 30, 2025. Their associated ...

Q3 2025 Earnings Call Transcript November 3, 2025 Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $2.66, ...

Discover why Kimberly-Clark Corporation could be a smart buy now with its improved valuation and highest dividend yield in ...

Edmond de Rothschild REIM straddles private rented homes and affordable housing. James Riding speaks to DJ Dhananjai and ...

Maher Tarabishi is in custody while his family tries to care for son Wael, who lives in Arlington and has a rare genetic disease.| Opinion ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2025 results of operations.

Phase 3 LUGANO and LUCIA clinical trials for DURAVYU™ in wet AMD fully enrolled and on track for data readout beginning in mid-2026 –– ...

Poor indoor air quality silently harms India’s workforce and economy, experts explain how clean air indoors boosts ...